Nanocap Group AB Series B (NANOC-B) fair value: what the stock is really worth
As of Oct 20, 2026: fair value (intrinsic value) of Nanocap Group AB Series B stock SEK 7.07, price SEK 4.30, upside +64.4%, quality 41 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range kr 3.08 – kr 44.37 · fair‑value band kr 5.30 – kr 8.84 · the kr 4.30 price screens below the kr 7.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.
Follow Nanocap Group AB Series B in your weekly email
Every Wednesday you see whether Nanocap Group AB Series B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
NanoCap Group AB (publ), previously known as New Equity Venture International AB, is a private equity, venture capital and family ownership firm, specializing in early venture, middle venture and late venture, bridge, mature and growth stage investments.
Show moreShow less
It usually invests in both listed and unlisted companies that are mainly into high-end technologies, as well as SaaS for e-commerce. The firm invests in companies that are based in in the regions of Scandinavia, Sweden, United Kingdom and United States.
It also acts as an advisor for companies in its holding. The firm was formerly known as Stureguld AB, after that, New Equity Venture International AB, and in November 2021, it changed its name to NanoCap Group AB (publ).
NanoCap Group AB (publ) was founded in 2010 and is headquartered in Stockholm, Sweden with additional offices in New York, New York; London, United Kingdom and Stockholm, Sweden.
Stock analysis
Nanocap Group AB Series B (NANOC-B) currently trades at kr 4.30, while our model-based Fair Value estimate is kr 7.07, implying the stock looks roughly 39.2% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 4 models at a data quality of 94/100, which puts the data coverage at low.
Scenario range: kr 5.30 (bear) to kr 8.84 (bull), the price of kr 4.30 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Nanocap Group AB Series B reported revenue of −23.1M SEK in FY2025 versus 49.6M SEK in FY2021. Reported net income was −23.1M SEK in FY2025.
Key figures
Market cap 24.6M SEK (≈ $2.5M) Micro · P/S ratio 0.57 · EPS (TTM) kr −3.92 · Net margin −52.6% · Return on equity −42.2% · Return on assets (EBIT) −37.6% · Operating margin −4.1% · Revenue (TTM) 42.5M SEK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 30% below its 52-week high and 40% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −12% fair-value upside, at 64%, NANOC-B screens cheaper than that median.
Fair Value models
Bearkr 5.30Fair Value kr 7.07Bullkr 8.84
Price kr 4.30 · Upside +64.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.6/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Sweden: IMF forecast 2.0% a year to 2030, 2.9% from 2016 to 2025) that is about +15.2% a year for the price.
Compare Nanocap Group AB Series B with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 664 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score41 · Bottom 25%
Fair Value upside+64.4% · Above median
Profitability
Return on assets−43.8% · Bottom 25%
Net margin (12 months)−52.6% · Bottom 25%
Operating margin (12 months)−4.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)1.4% · Below median
Valuation Multiplesvs Asset Management median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Nanocap Group AB Series B Fair Value". https://www.fairvalue-calculator.com/stock/NANOC-B
Frequently asked questions
Is Nanocap Group AB Series B (NANOC-B) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of kr 7.07 versus a price of kr 4.30, about +64% upside (undervalued).
What is the fair value of NANOC-B?
Our model-based fair value for Nanocap Group AB Series B is kr 7.07 (as of Oct 4, 2026), built from audited fundamentals. The current price: kr 4.30.
What is the quality score of NANOC-B?
Nanocap Group AB Series B has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nanocap Group AB Series B (NANOC-B)?
Our model-based price target is the fair value of kr 7.07 (as of Oct 4, 2026) from 2 valuation models. Cautious scenario kr 5.30, optimistic scenario kr 8.84. It is a calculation from audited fundamentals, not an analyst target.
What is the Nanocap Group AB Series B stock forecast for 2026?
Our models put fair value at kr 7.07, about +64% upside versus a price of kr 4.30 (undervalued). Cautious scenario kr 5.30, optimistic scenario kr 8.84. The calculation is refreshed regularly with new filings.
What is the revenue of Nanocap Group AB Series B (NANOC-B)?
Nanocap Group AB Series B reported trailing-twelve-month revenue of about 42.5M SEK (latest available figure, as of Oct 4, 2026).
What growth is priced into Nanocap Group AB Series B (NANOC-B)?
For today's price to be fair in a discounted-cash-flow model, Nanocap Group AB Series B would have to grow free cash flow by +17.5 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). As of Oct 4, 2026.
What discount rate (WACC) does the fair value of NANOC-B use?
Our models discount Nanocap Group AB Series B at 9.7 %: a base by market capitalisation (nano), damped by beta 1.07, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nanocap Group AB Series B that is +17.5 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How fast is the sector of Nanocap Group AB Series B (NANOC-B) growing?
The median revenue growth in the sector is +6.9 % a year. That is the yardstick for the growth priced into Nanocap Group AB Series B (+17.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nanocap Group AB Series B (NANOC-B)?
The free-cash-flow yield on the price is 2.65 %: that much free cash flow Nanocap Group AB Series B produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nanocap Group AB Series B (NANOC-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nanocap Group AB Series B it is kr 7.07 per share (as of Oct 4, 2026), against a price of kr 4.30. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Nanocap Group AB Series B stock overvalued or undervalued in 2026?
As of Oct 4, 2026, NANOC-B trades below its calculated fair value: price kr 4.30, fair value kr 7.07, a gap of about +64% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NANOC-B?
No. The price is what the market pays today (kr 4.30); the fair value is what the company's own numbers justify (kr 7.07). For Nanocap Group AB Series B the two are kr 2.77 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nanocap Group AB Series B worth?
The market values Nanocap Group AB Series B at about 24.6M SEK (market capitalisation, as of Oct 4, 2026). Per share that is kr 4.30; our models calculate a fair value of kr 7.07 per share.
What do the bullish and bearish scenarios say about NANOC-B?
Our models span a range for Nanocap Group AB Series B: cautious scenario kr 5.30, base kr 7.07, optimistic kr 8.84 per share (as of Oct 4, 2026, price kr 4.30). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nanocap Group AB Series B (NANOC-B)?
Balance-sheet figures for Nanocap Group AB Series B (as of Oct 4, 2026): return on equity −42.2%. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is NANOC-B from its 52-week high?
Nanocap Group AB Series B trades at kr 4.30, about 30% below its 52-week high of kr 6.10 and 40% above the low of kr 3.08 (as of Oct 20, 2026). Distance from the high says nothing about value: that is what the fair value of kr 7.07 is for.
Which stocks are comparable to Nanocap Group AB Series B?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nanocap Group AB Series B stock attractive at the current price?
The data as of Oct 4, 2026: price kr 4.30, calculated fair value kr 7.07 (+64%), Quality Score 41/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NANOC-B calculated?
We run Nanocap Group AB Series B through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 7.07, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. Nanocap Group AB Series B currently trades 39 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nanocap Group AB Series B (NANOC-B)?
The closing price on Oct 20, 2026 was kr 4.30. Our model-based fair value is kr 7.07, about +64% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nanocap Group AB Series B right now?
The large discount to fair value meets weak quality (41/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (kr 5.30). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Nanocap Group AB Series B
How large is the market capitalisation of Nanocap Group AB Series B (NANOC-B)?
The market capitalisation of Nanocap Group AB Series B is 24.6M SEK (≈ $2.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nanocap Group AB Series B (NANOC-B)?
The price-to-sales ratio of Nanocap Group AB Series B is 0.57 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nanocap Group AB Series B (NANOC-B)?
Earnings per share at Nanocap Group AB Series B are kr −3.92. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nanocap Group AB Series B (NANOC-B)?
The net margin of Nanocap Group AB Series B is −52.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nanocap Group AB Series B (NANOC-B)?
The return on equity (ROE) of Nanocap Group AB Series B is −42.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nanocap Group AB Series B (NANOC-B)?
On an EBIT basis the return on assets of Nanocap Group AB Series B is −37.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nanocap Group AB Series B (NANOC-B)?
The operating margin of Nanocap Group AB Series B is −4.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nanocap Group AB Series B (NANOC-B)?
Revenue at Nanocap Group AB Series B is growing +1.4% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nanocap Group AB Series B (NANOC-B)?
Earnings per share at Nanocap Group AB Series B are growing −64.0% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Nanocap Group AB Series B in the live analysis
One click puts Nanocap Group AB Series B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 4, 2026